Phaxiam Therapeutics Aktie 128791862 / FR001400K4B1
1.70
EUR
0.01
EUR
0.59%
02.01.2025
PAR
| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Watchlist | |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Historisch | Analysen | |||||
Kurse + Charts + Realtime
News + Analysen
Fundamental
zugeh. Wertpapiere
Phaxiam Therapeutics Dividenden Kalender
| Datum | Name | Rendite * | Dividende | Währung |
|---|---|---|---|---|
| 2023 | Phaxiam Therapeutics | 0.00 | 0.00 | EUR |
| 2022 | Phaxiam Therapeutics | 0.00 | 0.00 | EUR |
| 2021 | Phaxiam Therapeutics | 0.00 | 0.00 | EUR |
| 2020 | Phaxiam Therapeutics | 0.00 | 0.00 | EUR |
| 2019 | Phaxiam Therapeutics | 0.00 | 0.00 | EUR |
| 2018 | Phaxiam Therapeutics | 0.00 | 0.00 | EUR |
| 2017 | Phaxiam Therapeutics | 0.00 | 0.00 | EUR |
| 2016 | Phaxiam Therapeutics | 0.00 | 0.00 | EUR |
| 2015 | Phaxiam Therapeutics | 0.00 | 0.00 | EUR |
| 2014 | Phaxiam Therapeutics | 0.00 | 0.00 | EUR |
Zu diesem Datensatz liegen uns leider keine Daten vor.
Phaxiam Therapeutics Termine
| Unternehmen | Event | Datum |
|---|---|---|
| Phaxiam Therapeutics | Quartalszahlen | 19.03.2025 |
| Phaxiam Therapeutics | Quartalszahlen | 14.05.2025 |
| Phaxiam Therapeutics | Quartalszahlen | 18.09.2025 |
| Phaxiam Therapeutics | Quartalszahlen | 12.11.2025 |
Phaxiam Therapeutics vergangene Termine
| Terminart | Info | Datum |
|---|---|---|
| Quartalszahlen | Q3 2024 Earnings Release | 13.11.2024 |
| Quartalszahlen | Q2 2024 Earnings Release | 25.09.2024 |
| Hauptversammlung | Annual General Meeting | 28.06.2024 |
| Quartalszahlen | Q1 2024 Earnings Release | 15.05.2024 |
| Quartalszahlen | Q4 2023 Earnings Release | 20.03.2024 |
| Quartalszahlen | Q3 2023 Earnings Release | 14.11.2023 |
| Quartalszahlen | Q2 2023 Earnings Release | 21.09.2023 |
Aktionärsstruktur
| Inhaber | in % |
|---|---|
| Royance Sélection Internationale | 2.20 |
| Auriga Partners SA | 1.24 |
| Afer - Flore | 0.96 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 114 | 172 | 217 | 206 | 181 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Bilanz (in Mio. EUR) - Aktiva
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 192 | 150 | 82 | 50 | 40 |
| Summe Anlagevermögen | 4 | 18 | 37 | 31 | 27 |
| Summe Aktiva | 195 | 168 | 119 | 80 | 67 |
Bilanz (in Mio. EUR) - Passiva
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 14 | 22 | 33 | 54 | 44 |
| Summe Eigenkapital | 181 | 146 | 86 | 27 | 23 |
| Summe Passiva | 195 | 168 | 119 | 80 | 67 |
Adresse
| 60, avenue Rockefeller, 69008 Lyon | |
| Telefon | +33 (4) 78-74-44-38 |
| URL | http://www.phaxiam.com |
Management
|
Anne-Cécile Fumey
Director-Human Resources |
|
Cindy Fevre
Chief Scientific Officer |
|
Céline Breda
Chief Technical Officer |
|
Didier Hoch
Chairman |
|
Eric Jean Marie Leire
Independent Director |
|
Eric Soyer
Deputy CEO, Chief Financial & Operating Officer |
|
Frédérique Vieville
Chief Regulatory Officer |
|
Gil Beyen
Vice Chairman |
|
Hilde Windels
Independent Director |
|
Jérôme Bailly
Chief Quality Officer & Deputy CEO |
|
Karine Charton
Chief Business Officer |
|
Leila Nicolas
Director |
|
Martine Ortin George
Independent Director |
|
Pascal Birman
Chief Medical Officer |
|
Philippe Archinard
Independent Director |
|
Robert Sebbag
Independent Director |
|
Thibaut du Fayet
Chief Executive Officer |